Pages

▼
Tuesday, July 30, 2024

Drug Channels News Roundup, July 2024: My $0.02 on FTC’s PBM Report, GoodRx & Humira, Averon = CVS + Cardinal, IRA vs. 340B, and My Favorite Chart

›
Bello! The hot and hazy days of summer are here. Go for a swim to cool off and then enjoy this refreshing selection of articles chosen by Dr...
Monday, July 29, 2024

Informa Connect’s Medicaid Drug Rebate Program Summit

›
Informa Connect’s Medicaid Drug Rebate Program Summit September 23-25, 2024 | Chicago, IL Drug Channels readers save 10% with code 24DRCH...
Friday, July 26, 2024

Crafting Effective, Patient-Centric Channel Strategies

›
Today’s guest post comes from Joshua Guinter, Vice President of Channel Strategy and Product Access at Cencora. Josh discusses the importa...
Tuesday, July 23, 2024

Gross-to-Net Bubble Update: 2023 Pricing Realities at 10 Top Drugmakers

›
It’s time for Drug Channels ’ annual update on pricing at the largest pharmaceutical manufacturers. This year’s review includes the followin...
Friday, July 19, 2024

Optimizing Product Commercialization in Today’s IDN Environment

›
Today’s guest post comes from Greg Skalicky, President, EVERSANA; Krista Pinto, President, Deployment Solutions, EVERSANA; and Faruk Abdul...
Tuesday, July 16, 2024

PBM Power: The Gross-to-Net Bubble Reached $334 Billion in 2023—But Will Soon Start Deflating

›
Last week, the Federal Trade Commission (FTC) released its interim report on pharmacy benefit managers (PBMs). The report’s unsubtle subtitl...
Friday, July 12, 2024

At the Breaking Point: The Unsustainable Future of Government Drug Discount Programs

›
Today’s guest post comes from Gavin Magaha, Senior Director of External Affairs and Policy at Kalderos. Gavin discusses the three key rea...
Tuesday, July 09, 2024

Who Will Pay for Prescription Drugs in 2032: Four Takeaways from the New Government Forecasts

›
The econowonks at the Centers for Medicare & Medicaid Services (CMS) recently released the latest projections for U.S. spending on healt...
Friday, June 28, 2024

Breaking Down Medication Access and Affordability Barriers

›
Today’s guest post comes from Kristina Crockett, VP of Product Management at CoverMyMeds. Kristina discusses challenges patients face acce...
Tuesday, June 25, 2024

Drug Channels News Roundup, June 2024: Cordavis Humira Update, OptumRx’s New Biosim Biz, Generic Drugs' Wild Ride, IRA Predictions, and Dr. G on Med School

›
Happy 248th birthday, America! Before you launch your July 4 festivities, Drug Channels offers some fireworks of its own: CVS Health’s Cord...
Monday, June 24, 2024

Meet the Four Executives Headlining the Drug Channels Leadership Forum

›
Good news, everyone! We have secured four outstanding fireside chat participants for our inaugural Drug Channels Leadership Forum , which wi...
Friday, June 21, 2024

Mark Cuban: Five Ways that Big PBMs Hurt U.S. Healthcare–And How We Can Fix It (rerun)

›
This week, I’m rerunning some popular posts while I prepare for today's live video webinar: The 340B Drug Pricing Program: Trends, Contr...